11 results
424B5
MLYS
Mineralys Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:35pm
with hypertension and CKD. We believe that our product candidate holds promise to be an innovative solution for the rapidly growing unmet need … in subjects with hypertension and CKD. We believe that our product candidate holds promise to be an innovative solution for the rapidly growing unmet
DEF 14A
MLYS
Mineralys Therapeutics Inc
9 Apr 24
Definitive proxy
7:15am
Innovative Technology Fund, the world’s first public-private fund focused on the development of new medicines for low- and middle-income countries. Dr
S-3
MLYS
Mineralys Therapeutics Inc
21 Mar 24
Shelf registration
7:30am
to be an innovative solution for the rapidly growing unmet need in multiple cardiorenal metabolic disorders.
Hypertension is one of the most common medical … that our product candidate holds promise to be an innovative solution for the rapidly growing unmet need in multiple cardiorenal metabolic disorders
10-Q
v5z2y 4e53pptjb
15 May 23
Quarterly report
5:25pm
DRS/A
l3zavfo32x nj30
29 Dec 22
Draft registration statement (amended)
12:00am
DRS/A
f0zf3h8 qscek3
7 Dec 22
Draft registration statement (amended)
12:00am
DRS
9ic bkbm7h
4 Nov 22
Draft registration statement
12:00am
- Prev
- 1
- Next